Archon Biosciences develops AI-driven Antibody Cages to enhance antibody treatments by improving target engagement and biodistribution.

Talus Bioscience is a drug discovery company that uses AI to develop therapies targeting transcription factors involved in cancers.

AdaptX is a Seattle-based company that specializes in self-serve clinical management solutions, using AI-driven technology to assess and improve care across patients using data from electronic medical records.